Search

Search Constraints

You searched for: Author/Creator Sabnis, Amit J

Search Results

1. Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG). Issue 10 (8th April 2022)